We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+19.44%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$28.4B
AUM Growth
+$3.28B
(+13%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
22.69%
Holding
696
New
203
Increased
144
Reduced
156
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$382M |
| 2 |
JPMorgan Chase
JPM
|
+$330M |
| 3 |
Arista Networks
ANET
|
+$263M |
| 4 |
Zebra Technologies
ZBRA
|
+$217M |
| 5 |
Walt Disney
DIS
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$366M |
| 2 |
Cisco
CSCO
|
+$309M |
| 3 |
United Airlines
UAL
|
+$265M |
| 4 |
Western Digital
WDC
|
+$196M |
| 5 |
Medtronic
MDT
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Consumer Discretionary | 10.61% |
| 3 | Industrials | 10.56% |
| 4 | Healthcare | 9.33% |
| 5 | Financials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Acumen Pharmaceuticals
ABOS
$176M
| $1.09M | ﹤0.01% |
939,603
| – | – |
|
502
Context Therapeutics
CNTX
$44.5M
| $1.09M | ﹤0.01% |
1,663,355
| – | – |
|
503
Intelligent Bio Solutions
INBS
$4.74M
| $1.06M | ﹤0.01% |
61,389
| – | – |
|
504
argenx
ARGX
$54.1B
| $1.01M | ﹤0.01% |
+1,836
| New | +$1.07M |
|
505
Qorvo
QRVO
$8.74B
| $965K | ﹤0.01% |
11,366
-1,570
| -12% | -$113K |
|
|
PROF
506
Profound Medical
PROF
$269M
| $944K | ﹤0.01% |
160,000
| – | – |
|
|
SVCO
507
Silvaco Group
SVCO
$256M
| $940K | ﹤0.01% |
199,194
| – | – |
|
|
UPB
508
Upstream Bio Inc
UPB
$395M
| $933K | ﹤0.01% |
85,000
| – | – |
|
509
PayPal
PYPL
$50.5B
| $870K | ﹤0.01% |
+11,712
| New | +$802K |
|
510
Lucid Diagnostics
LUCD
$184M
| $849K | ﹤0.01% |
738,277
-1,149,566
| -61% | -$1.48M |
|
511
Visteon
VC
$2.78B
| $844K | ﹤0.01% |
+9,044
| New | +$744K |
|
512
Genelux
GNLX
$119M
| $818K | ﹤0.01% |
285,000
| – | – |
|
|
RHLD
513
Resolute Holdings Management
RHLD
$1.07B
| $761K | ﹤0.01% |
23,872
| – | – |
|
514
Iron Mountain
IRM
$36.1B
| $686K | ﹤0.01% |
6,689
-169,895
| -96% | -$16M |
|
515
Old Dominion Freight Line
ODFL
$44.9B
| $678K | ﹤0.01% |
+4,176
| New | +$666K |
|
516
Coinbase
COIN
$40.5B
| $610K | ﹤0.01% |
+1,739
| New | +$407K |
|
|
CLYM
517
Climb Bio
CLYM
$804M
| $602K | ﹤0.01% |
+485,364
| New | +$604K |
|
518
Voya Financial
VOYA
$9.19B
| $592K | ﹤0.01% |
+8,340
| New | +$535K |
|
519
Verastem
VSTM
$610M
| $547K | ﹤0.01% |
+131,770
| New | +$825K |
|
520
Boyd Gaming
BYD
$6.06B
| $504K | ﹤0.01% |
+6,438
| New | +$460K |
|
521
Fair Isaac
FICO
$22.5B
| $490K | ﹤0.01% |
+268
| New | +$503K |
|
522
EXL Service
EXLS
$5.29B
| $478K | ﹤0.01% |
+10,922
| New | +$499K |
|
523
Owlet
OWLT
$160M
| $471K | ﹤0.01% |
56,075
-143,925
| -72% | -$719K |
|
524
Adicet Bio
ACET
$74.7M
| $400K | ﹤0.01% |
40,979
| – | – |
|
525
PTC
PTC
$16B
| $396K | ﹤0.01% |
2,300
-60,230
| -96% | -$9.71M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2025 Portfolio in Review
As of Q2 2025, Alyeska Investment Group held 696 positions worth $28.4B, up 13% from $25.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Alyeska Investment Group's Q2 2025 filing shows 203 new, 144 increased, 156 reduced and 154 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,335,726 shares worth $412M. The largest sale was Amazon, an estimated $366M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q2 2025 buy was Alphabet (Google) Class A: 2,335,726 shares worth $412M.
- Alyeska Investment Group added most to JPMorgan Chase in Q2 2025, an estimated $330M increase.
- Alyeska Investment Group's biggest Q2 2025 reduction was Amazon, cutting an estimated $366M.
- Alyeska Investment Group fully exited Sherwin-Williams in Q2 2025, selling an estimated $188M.
- Alyeska Investment Group's ten largest holdings make up 23% of its $28.4B portfolio in Q2 2025.
- Alyeska Investment Group opened 203 new positions and closed 154 in Q2 2025.
- Alyeska Investment Group's portfolio value rose 13% quarter-over-quarter to $28.4B.
Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.